PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcpsycBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Psychiatry
 
BMC Psychiatry. 2011; 11: 122.
Published online 2011 July 30. doi:  10.1186/1471-244X-11-122
PMCID: PMC3163521
Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006
Anna Nyhlén,1 Mats Fridell,corresponding author2 Martin Bäckström,3 Morten Hesse,4 and Peter Krantz5
1Dept of Psychiatry Lund University Hospital SE - 221 85 Lund, Sweden
2Lund University, Dept of Psychology & Vaxjo University, School of Education, Psychology and Sport Science, SE - 35195, Växjö, Sweden
3Lund University, Dept of Psychology B 213, SE - 221 00 Lund, Sweden
4University of Aarhus, Centre for Alcohol and Drug Research Artillerivej 90, 2300 Copenhagen S, Denmark
5Dept of Forensic Medicine Lund University Hospital, S - 221 85 Lund, Sweden
corresponding authorCorresponding author.
Anna Nyhlén: anna.nyhlen/at/skane.se; Mats Fridell: mats.fridell/at/psychology.lu.se; Martin Bäckström: martin.backstrom/at/psychology.lu.se; Morten Hesse: mh/at/crf.au.dk; Peter Krantz: rmlu/at/rmv.se
Received September 27, 2010; Accepted July 30, 2011.
Abstract
Background
Few longitudinal cohort studies have focused on the impact of substances abused and psychiatric disorders on premature mortality. The aim of the present study was to identify predictors of increased risk of drug related death and non drug related death in substance abusers of opiates, stimulants, cannabis, sedatives/hypnotics, hallucinogens and alcohol over several decades.
Methods
Follow-up study of a consecutive cohort of 561 substance abusers, admitted to a detoxification unit January 1970 to February 1978 in southern Sweden, and followed up in 2006. Demographic and clinical data, substance diagnoses and three groups of psychiatric diagnoses were identified at first admission. Causes of death were coded according to ICD-10 and classified as drug related deaths or non drug related deaths. To identify the incidence of some probable risk factors of drug related premature death, the data were subjected to a competing risks Cox regression analysis.
Results
Of 561 patients in the cohort, 11 individuals had either emigrated or could not be located, and 204/561 patients (36.4%) were deceased by 2006. The cumulative risk of drug related death increased more in the first 15 years and leveled out later on when non drug related causes of death had a similar incidence. In the final model, male gender, regular use of opiates or barbiturates at first admission, and neurosis were associated with an increased risk of drug related premature death, while cannabis use and psychosis were associated with a decreased risk. Neurosis, mainly depression and/or anxiety disorders, predicted drug related premature death while chronic psychosis and personality disorders did not. Chronic alcohol addiction was associated with increased risk of non drug related death.
Conclusions
The cohort of drug abusers had an increased risk of premature death to the age of 69. Drug related premature death was predicted by male gender, the use of opiates or barbiturates and depression and anxiety disorders at first admission. The predicted cumulative incidence of drug related death was significantly higher in opiate and barbiturate abusers over the observed period of 37 years, while stimulant abuse did not have any impact. Alcohol contributed to non drug related death.
Keywords: drug related death, risk factor, gender, competing risks Cox regression, cohort study, Predictors
Articles from BMC Psychiatry are provided here courtesy of
BioMed Central